Ireland, Scotland and Wales signs MOU on HTAs

HIQA
Pictured signing the MoU are Dr Máirín Ryan, HIQA’s Deputy CEO and Director of Health Technology Assessment, and Phelim Quinn, HIQA CEO.
Dr Peter Groves, Chair of Health Technology Wales, and Director Dr Susan Myles
Dr Iain Robertson, Chair of Scottish Health Technology Group and Unit Head Edward Clifton.

HIQA undertakes HTAs in Ireland to inform national policy and health service decisions.

The MoU establishes a collaborative approach to the identification and assessment of new health technologies between HIQA, Health Technology Wales and the Scottish Health Technology Group. These bodies assess and give guidance on health technologies within their national healthcare systems.

Dr. Máirín Ryan, HIQA’s Deputy CEO and Director of Health Technology Assessment, said: “The MoU aims to formalise working in partnership with HTA bodies across these three countries, including opportunities to collaborate on and co-produce evidence reviews on health technologies. It will also improve shared understanding of work programmes and processes, ensuring the best use of resources for the people of each country and their respective care systems. ”

Advertisement
RCSI Leadership

“HIQA welcomes this opportunity to optimise the use of scarce HTA resources and expertise across the three countries and increase efficiencies through joint work.”

HIQA has recently worked successfully with the Scottish Health Technology Group on each country’s national assessments of mechanical thrombectomy to treat ischaemic stroke.

HIQA, along with the other HTA bodies, will be attending the Health Technology Assessment International (HTAi) Annual Meeting in Cologne in June 2019 to present the progress made through this new strategic alliance.